• 原料直供
• 试剂商城
• 直接询价

分类

• {SNA} Agonists, Antagonists, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Diversification Ready Pharma-Developed Compounds, Dopaminargics - Antagonists, Dopaminergics, Eli Lilly, GPCR Modulators, GPCR Proteins, Modulators and Antibodies, Membrane Protein Biology Tools, Neuroscience, Neurotransmission, Neurotransmitters, O, Serotonergics, 生化试剂, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学, 蛋白质及衍生物
• {SNA} Agonists, Antagonists, Approved Therapeutics/Drug Candidates, Biochemicals and Reagents, Cell Biol

相关文献及参考

• [2]. Olanzapine for Injection, powder, for solution for intramuscular use.
• [3]. Vucicevic L, et al. Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine. Autophagy. 2014;10(12):2362-78.
• [4]. Karpel-Massler G, et al. Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect. J Neurooncol. 2015 Mar;122(1):21-33.
• [5]. Coccurello R, et al. Chronic administration of olanzapine induces metabolic and food intake alterations: a mousemodel of the atypical antipsychotic-associated adverse effects. Psychopharmacology (Berl). 2006 Jul;186(4):561-71.
• [1]. APPROVED AGREED-UPON LABELING.
• [1]. APPROVED AGREED-UPON LABELING.
• [2]. Olanzapine for Injection, powder, for solution for intramuscular use.
• [3]. Vucicevic L, et al. Autophagy inhibition uncovers the neurotoxic action of the antipsychoti

安全信息